Physical stability, biocompatibility and potential use of hybrid iron oxide-gold nanoparticles as drug carriers

Journal of Nanoparticle Research

Volumn 15, Issue 6, 2013, Pages

  Barnett, Christopher M ^a   Gueorguieva, Mariana ^b   Lees, Martin R ^c   McGarvey, David J ^a   Hoskins, Clare ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Biocompatibility; Drug delivery; Gold nano shell; Hybrid nanoparticle; Magnetic nanoparticle; Stability

Indexed keywords

BIOACTIVITY; BIOCOMPATIBILITY; CELL CULTURE; CHEMICAL STABILITY; CONTROLLED DRUG DELIVERY; CONVERGENCE OF NUMERICAL METHODS; DRUG DELIVERY; FIBER OPTIC SENSORS; FREE RADICALS; IRON OXIDES; MAGNETIC NANOPARTICLES; METAL NANOPARTICLES; POLYETHYLENE GLYCOLS; TARGETED DRUG DELIVERY;

COATED NANOPARTICLES; FREE RADICAL PRODUCTIONS; GOLD NANO-SHELLS; HYBRID NANOPARTICLE; IMAGE GUIDED DRUG DELIVERIES; IMAGE GUIDED THERAPY; PANCREATIC ADENOCARCINOMA; PHYSIOLOGICAL CONDITION;

GOLD NANOPARTICLES;

DRUG CARRIER; FREE RADICAL; GOLD NANOPARTICLE; IRON; IRON OXIDE; MACROGOL; TIOGUANINE;

ARTICLE; BIOCOMPATIBILITY; CELL DIFFERENTIATION; CONJUGATION; CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; MONOCYTE; PANCREAS ADENOCARCINOMA; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

EID: 84877596537     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1706-2     Document Type: Article

References (29)

1. Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1-16
2. Arruebo M, Fernández-Pacheco R, Ibarra R (2007) Magnetic nanoparticles for drug delivery. Nano Today 2:22-32
3. Barnett CM, Gueorguieva M, Lees MR, McGarvey DJ, Darton RJ, Hoskins C (2012) Effect of the hybrid composition on the physicochemical properties and morphology of iron oxide-gold nanoparticles. J Nanopart Res 14:1170
4. Buzea C, Pacheco B II, Robbie K (2007) Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2:MR17-MR172
5. Chatterjee S, Bandyopadhyay A, Sarkar K (2011) Effect of iron oxide and gold nanoparticles on bacterial growth leading towards biological application. J Nanobiotechnol 9:34
6. Dobson J (2006) Magnetic nanoparticles for drug delivery. Drug Dev Res 67:55-60
7. Fadeel B, Garcia-Bennett AE (2010) Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 62:362-374
8. Hoskins C, Ouaissi M, Lima SC, Cheng WP, Loureirio I, Mas E, Lombardo D, Cordeiro-sa-Silva A, Ouaissi A, Kong Thoo Lin P (2010) The study of in vitro and in vivo anticancer activity of a novel formulation incorporating PAA and BNIPDaoct against pancreatic cancer. Pharmaceut Res 27:2694-2703
9. Hoskins C, Min Y, Gueorguieva M, McDougall C, Volovick A, Prentice P, Wang Z, Melzer A, Cuschieri A, Wang L (2012a) Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application. J Nanobiotechnol 10:27
10. Hoskins C, Wang L, Cuschieri A (2012b) The cytotoxicity of polycationic nanoparticles: common endpoint assays and alternative approaches for improved understanding of cellular response mechanism. J Nanobiotechnol 10:15
11. Hosoya H, Marunouchi T (1992) Differentiation and dedifferentiation of the human monocytic leukemia cell line, U937. Cell Strct Funct 17:263-269
12. Ji X, Shao R, Elliott AM, Stafford J, Esparza-Coss E, Bankson JA, Liang G, Luo Z-P, Park K, Markert J-T, Li C (2007) Bifunctional gold nanoshells with a superparamagnetic iron oxide: silica core suitable for both MR Imaging and photothermal therapy. J Phys Chem C 111:6245-6251
13. Józejczak A, Skumiel A (2011) Ultrasonic investigation of magnetic nanoparticles suspension with PEG biocompatible coating. J Magn Magn Mater 11:1509-1516
14. Katsanos K, Tsianos EV (2010) Non-TPMT determiniants of azathioprine toxicity in imflammatory bowel disease. Ann Gastroenterol 23:95-101
15. Lancaster DL, Patel N, Lennard L, Lilleyman JS (2001) 6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations. BJCP 56:531-539
16. Lu A-H, Salabas EL, Schüth F (2007) Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed 46:1222-1244
17. Lyer AK, Khaled G, Fang J, Maeda H (2006) Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11:812-818
18. Majumdar S, Tejo BA, Badawi AH, Moore D, Krise JP, Siahaan TJ (2009) Effect of modification of the physicochemical properties if ICAM-1-derived peptides on internalization and intracellular distribution in the human leukemic cell line HL-60. Mol Pharm 6:396-406
19. Manson J, Kumar D, Meenan BJ, Dixon D (2011) Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media. Gold Bull 4:99-105
20. Minotti G, Aust SD (1987) The requirement for Iron(III) in the initiation of lipid peroxidation by Iron(II) and hydrogen peroxide. J Biol Chem 262:1098-1104
21. Mishra S, Webster P, Davis ME (2004) PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol 83:97-111
22. 4 nano-magnetic fluid by co-precipitation method. Trans Nonferrous Met Soc China 18:393-398
23. Shubayev VI, Pisanic TR, Jun S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61:467-477
24. Sorensen M, Autrup H, Moller P, Hertel O, Jensen SS, Vinzents P, Knudsen LE, Loft S (2003) Linking exposure to environmental pollutants with biological effects. Mutat Res 544:255-271
25. Sun C, Lee JSH, Zhang M (2008) Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 60:1252-1265
26. Vila A, Gill H, McCallion O, Alonso MJ (2004) Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release 98:231-244
27. Wagstaff AJ, Brown SD, Holden MR, Craig GE, Plumb JA, Brown RE, Schreiter N, Chrzanowski W, Wheate NJ (2012) Cisplatin drug delivery using gold-coated iron oxide nanoparticles for enhanced tumour targeting with external magnetic fields. Inorg Chim Acta 393:328-333
28. Zaza G, Cheok M, Krynetskaia N, Thorn C, Stocco G, Hebert JM, McLeod H, Weinshilbourn RM, Relling MV, Evans WE, Klein TE, Altman RB (2010) Thiopurine pathway. Pharmacogenet Genomics 20:573-574
29. Zhu M-T, Feng W-Y, Wang B, Wang T-C, Gu Y-Q, Wang M, Wang Y, Ouyang H, Zhao Y-L, Chai Z-F (2008) Comparative study of pulmonary responses to nano- and submicron sized ferric oxide in rats. Toxicology 247:102-111